文献速递产科母胎医学

一步法与两步法妊娠期糖尿病筛查与妊娠结局比较:系统综述与Meta分析

One-Step Compared With Two-Step Gestational Diabetes Screening and Pregnancy Outcomes: A Systematic Review and Meta-analysis.
PubMed 文献 · Obstet Gynecol · 2022-10-05

该系统综述与Meta分析纳入4项随机对照试验(24,966例)和13项观察性研究(710,677例),比较一步法与两步法筛查妊娠期糖尿病的母婴结局。随机对照试验中,一步法组巨大儿发生率与两步法无差异(合并RR 0.95,95%CI 0.88-1.04),但妊娠期糖尿病诊断率和药物治疗率更高,新生儿重症监护病房入住率和新生儿低血糖发生率也更高。

要点

  • 随机对照试验中一步法与两步法筛查的巨大儿发生率无差异(合并RR 0.95,95%CI 0.88-1.04)。
  • 一步法筛查的妊娠期糖尿病诊断率更高(合并RR 2.13,95%CI 1.61-2.82)。
  • 一步法筛查的新生儿重症监护病房入住率(合并RR 1.12,95%CI 1.00-1.26)和新生儿低血糖发生率(合并RR 1.23,95%CI 1.13-1.34)更高。

核心结论

  • 尽管一步法筛查显著增加妊娠期糖尿病的诊断和治疗,但随机对照试验中一步法与两步法筛查的巨大儿发生率无差异。

研究设计与样本

  • 系统综述与Meta分析,纳入4项随机对照试验(24,966例)和13项观察性研究(710,677例),检索至2021年9月。
  • 检索数据库包括Ovid Medline(1946-)、EMBASE(1947-)、Scopus(1960-)、Cochrane Central和ClinicalTrials.gov。
  • 主要结局为巨大儿发生率,次要结局为预先选择的妊娠期糖尿病临床相关结局。

主要发现

  • 随机对照试验中,一步法与两步法筛查的巨大儿发生率无差异(合并RR 0.95,95%CI 0.88-1.04)。
  • 一步法筛查的妊娠期糖尿病诊断率更高(合并RR 2.13,95%CI 1.61-2.82),糖尿病药物治疗率也更高(合并RR 2.24,95%CI 1.21-4.15)。
  • 一步法筛查的新生儿重症监护病房入住率更高(合并RR 1.12,95%CI 1.00-1.26),新生儿低血糖发生率也更高(合并RR 1.23,95%CI 1.13-1.34)。
  • 在高品质随机对照试验和观察性研究的分析中,一步法筛查的巨大儿发生率更低(合并RR 0.97,95%CI 0.95-0.98),但妊娠期糖尿病诊断率、治疗率、新生儿重症监护病房入住率和新生儿低血糖发生率更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate short-term maternal and neonatal outcomes with one-compared with two-step testing for gestational diabetes mellitus (GDM). DATA SOURCES: A systematic review of randomized controlled trials (RCTs) and observational studies comparing one-step and two-step GDM testing strategies before September 2021 was conducted. We searched Ovid Medline (1946-), EMBASE (1947-), Scopus (1960-), Cochrane Central, and ClinicalTrials.gov . The primary outcome was rate of large-for-gestational age (LGA) neonates. Secondary outcomes were clinically relevant outcomes for GDM that were selected a priori. METHODS OF STUDY SELECTION: Titles, abstracts, and manuscripts were screened, selected, and reviewed by the first two authors. Four RCTs (24,966 patients) and 13 observational studies (710,677 patients) were analyzed. TABULATION, INTEGRATION, AND RESULTS: Pooled relative risks (RRs) were calculated with 95% CIs using random-effects models and were plotted graphically with forest plots. Study heterogeneity was evaluated using Cochran Q and Higgins I 2 tests. The quality of studies that met the inclusion criteria was evaluated with the Downs and Black checklist. Publication bias was assessed by using asymmetry of funnel plots and Harbord's test. There was no difference in the rate of LGA neonates (pooled RR 0.95; 95% CI 0.88-1.04) by testing strategy among RCTs, but patients who underwent one-step testing were more likely to be diagnosed with GDM (pooled RR 2.13; 95% CI 1.61-2.82) and treated with diabetes medications (pooled RR 2.24; 95% CI 1.21-4.15). One-step testing was associated with higher rates of neonatal intensive care unit (NICU) admission (pooled RR 1.12; 95% CI 1.00-1.26) and neonatal hypoglycemia (pooled RR 1.23; 95% CI 1.13-1.34). In analysis of high-quality RCTs and observational studies, one-step testing was associated with a lower rate of LGA neonates (pooled RR 0.97; 95% CI 0.95-0.98), but higher rates of GDM diagnosis, treatment, NICU admission, and neonatal hypoglycemia. CONCLUSION: Despite a significant increase in GDM diagnosis and treatment with one-step testing, there is no difference in rate of LGA neonates compared with two-step testing among RCTs. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42021252703.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Brady M, Hensel DM, Paul R, et al. One-Step Compared With Two-Step Gestational Diabetes Screening and Pregnancy Outcomes: A Systematic Review and Meta-analysis. Obstet Gynecol. 2022. PMID: 36201772. doi:10.1097/AOG.0000000000004943

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。